Holdings
First Trust Nasdaq Pharmaceuticals ETF
As of Jun 30, 2026, First Trust Nasdaq Pharmaceuticals ETF reported 50 positions worth US$36.2M. Largest: Eli Lilly And Company, Abbvie Inc. and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 2,347 | US$2.82M | +247 | Jun 30, 2026 |
| Abbvie Inc. | 10,640 | US$2.68M | +1,120 | Jun 30, 2026 |
| Merck & Company, Inc. | 19,942 | US$2.56M | +2,099 | Jun 30, 2026 |
| Johnson & Johnson | 9,939 | US$2.52M | +1,046 | Jun 30, 2026 |
| Bristol-myers Squibb Company | 39,590 | US$2.28M | +4,168 | Jun 30, 2026 |
| Biogen Inc. | 6,436 | US$1.39M | +677 | Jun 30, 2026 |
| Viatris Inc. | 82,694 | US$1.31M | +8,705 | Jun 30, 2026 |
| Cardinal Health, Inc. | 5,386 | US$1.28M | +567 | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 2,485 | US$1.23M | +262 | Jun 30, 2026 |
| Amgen Inc. | 3,181 | US$1.15M | +335 | Jun 30, 2026 |